IVA
InventivaFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
Current thesis
Composite grade F from latest DB weights. Momentum 17.6 / Value 41.1
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.0.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
18
Value
41
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-22
Fundamentals
As of 2026-07-21 • Vendor: Data Vendor v1
Scores
As of 2026-07-22 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-22
Investment thesis
As of 2026-07-22
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $15.60
Why
Momentum18 · Δ7d +9.7
Value41 · Δ7d -0.0
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
18
40% active weight
Current posture
7d trendImproving
Δ7d
+9.7
Δ21d
+15.7
Value
41
60% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-0.1
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 17.6 / Value 41.1
Fundamentals (TTM)As of 2026-07-21
Fundamentals (TTM)
As of 2026-07-21
Market Cap
$1.06B
Beta
0.29
Shares Out
236.23M
P/E (TTM) · Derived
-2.1
P/S (TTM)
55.31
P/FCF (TTM) · Derived
-5.12
Rev YoY
+10763.4%
EPS YoY
-71.3%
Gross Margin
+33.3%
Op Margin
-795.3%
Net Debt
-$46.85M
Current Ratio
3.15
As of 2026-07-22 • Updated nightlySource: Internal modelMethodology